|
Written by Keith McLachlan
|
|
Monday, 05 April 2010 |
|
For the last week or two I've run a poll on this website. The poll listed six arguably pennystock shares and asked which one would be worth investing in. The results are as below:  Absolute comes out the clear favourite, probably because it is busy being used as a vehicle for the reverse listing for some sizable platinum assets. An exciting story headed by some exciting figures and topped by a share consolidation all generating this interest. BioScience Brands came out the second favourite with 18.8% of the votes. This company is the current reincarnation of the Wellco listing that bombed and currently has cipla Medpro's Muscle Science spun into it. Other brands include KGB, Herbology, Bioharmony, and Phyto Nova. An interesting portfolio of brands, but the numbers coming out the company are yet to impress me much. What I found the most interesting was that my personal choice, Ububele, actually came last in the poll. The Group has interests in agricultural products for farmers and value-added produce. Ububele is a far cry from your typical pennystock and in fact has quality and profitable operations, a sizeable bank account and a rosy-looking future. Ububele directors intend to do a 50-for-1 share consolidation and a R25 million rights issue to help grow the business. I'm a bottom-up investor looking at businesses on an individual basis and with a strong value-bias. While I would rather invest in an established and profitable business and not "punt" a risky pennystock, it is interesting to see how contrarian my opinion is concerning pennystocks selection. I cannot recall who said this, but it always rings true: "Value investing is lonely business". On this same topic I've now decided to run another poll for a couple promising small caps... Vote here for which one you think will do the best!
|
|
|
Written by Keith McLachlan
|
|
Monday, 29 March 2010 |
|
The AltX housing developer, RBA Holdings, last week announced its audited financial results for the year ended 31 December 2009. The Group has been severly impacted by the recession, local private property bust and the bank's basically freezing home loan credit growth. These factors all contributed to the Group's tangible NAV dropping just under 39% to 19.80c. This acid test value for the troubled Group reflects against the current share price of 16c to show that the market is factoring in future losses (at least). While current loss of 10.95c per share reflects badly versus this tangible NAV, the Group did manage to produce a gross profit of R25 million. Albeit, this was on the back of a 56% drop in revenue for the Group. This drop is simply reflective of the fact that only 266 homes were completed and sold during the period versus the previous financial period's 782 homes. The Credit Crisis' shutdown of credit growth in banks is really the major culprit for this drop in demand. On a positive note, the directors report that "...a big success of the 2009 financial year was the successful completion and letting of 176 sectional title units in Protea Glen, Soweto. As at 31 December 2009 the first phase consisting of 100 units was fully tenanted." Critically regarding the prospects of the Group the directors cite how "...recent months have seen a continued relaxing by banks of their lending criteria. This along with an improvement in the affordability of mortgage loans due to lower interest rates and an improvement in clients` disposable income levels have resulted in a continued improvement in monthly sales. Although natural attrition in the workforce has taken place, the group has retained its sales, administration and production capacity through this difficult period and is well placed to take full advantage of the anticipated recovery in the affordable housing market." Coupled with the surprise interest rate drop by Gill Marcus last week, perhaps RBA's prospects are finally looking a bit better.
|
|
|
Written by Keith McLachlan
|
|
Thursday, 25 March 2010 |
|
Yesterday Blue Financial Services, the troubled pan-African micro lenders, released a further cautionary annnouncement backing up the original cautionary that was put out on 10 November 2010 and saying how negotiations are still continuing. While there is nothing amazing in that, the directors did disclose some further information: "Shareholders are advised that the strategic options under consideration relate to either a potential recapitalisation of the company or, alternatively, a potential offer being made for the company." It is likely that it is ABSA that is the other party in this potential deal. ABSA was left with an unwanted 16.83% stake after the SSF fallout from cortex Securities. ABSA would also have sufficient funds to recapitalise Blue and logical reason to also consider just buying the Group and extending its funds internally. This scenario is going to end one of three ways: - Blue gets bought and its current shareholders get a nice little premium (perhaps an arbitrage opportunity),
- Blue gets loans and struggles through (shareholders maybe one day see a profit and some capital appreciation), or
- ABSA walks away, loses its stake, and Blue folds under lack of financing and mounting bad debts.
The most likely is probably the first ending to the scenario, but the other two could quite possibly also happen. The fact that the share price actually dipped 3.7% by close of yesterday implies that the market disagrees with me about the first option (which would most probably be at a price higher than the current market price and, the market knowing this, would've bumped up the price)....
|
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
| Results 21 - 24 of 569 |